Page last updated: 2024-09-05

deferasirox and Infections, Pseudomonas

deferasirox has been researched along with Infections, Pseudomonas in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Moreau-Marquis, S; O'Toole, GA; Stanton, BA	1

Other Studies

1 other study(ies) available for deferasirox and Infections, Pseudomonas

Article	Year
Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. American journal of respiratory cell and molecular biology, 2009, Volume: 41, Issue:3 Topics: Anti-Bacterial Agents; Benzoates; Biofilms; Cells, Cultured; Conalbumin; Cystic Fibrosis; Deferasirox; Deferoxamine; Epithelial Cells; Humans; Iron Chelating Agents; Pseudomonas Infections; Tobramycin; Triazoles; United States; United States Food and Drug Administration	2009

Article

Year

Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells.

American journal of respiratory cell and molecular biology, 2009, Volume: 41, Issue:3

Topics: Anti-Bacterial Agents; Benzoates; Biofilms; Cells, Cultured; Conalbumin; Cystic Fibrosis; Deferasirox; Deferoxamine; Epithelial Cells; Humans; Iron Chelating Agents; Pseudomonas Infections; Tobramycin; Triazoles; United States; United States Food and Drug Administration

2009